FDA Guidance To Clarify Purpose Of PMA Condition-Of-Approval Studies
This article was originally published in The Gray Sheet
Executive Summary
FDA aims to clarify in an upcoming guidance document the difference between condition-of-approval studies for premarket approval application devices and postmarket surveillance studies.